ArticleThe oncologist2024

Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors.

Adriana M Kahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.